Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Antimicrobial Chemotherapy|May 1, 2001
Successful administration of quinupristin/dalfopristin in the outpatient settingS J Rehm, D R Graham, L Srinath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1985
Invasive pulmonary aspergillosis in adult acute leukemia: clinical clues to its diagnosisS L Gerson, G H Talbot, E Lusk, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 28, 2007
Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantationD H Monkowski, P Axelrod, T Fekete, et al.
Annals of Internal Medicine|March 1, 1984
Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemiaS L Gerson, G H Talbot, S Hurwitz, et al.
The American Journal of Medicine|July 1, 1985
Discriminant scorecard for diagnosis of invasive pulmonary aspergillosis in patients with acute leukemiaS L Gerson, G H Talbot, S Hurwitz, et al.
The American Journal of Medicine|November 1, 1989
Risk factors for Amphotericin B-associated nephrotoxicityM A Fisher, G H Talbot, G Maislin, et al.
Journal of Clinical Microbiology|February 1, 1992
Sporothrix schenckii fungemia without disseminated sporotrichosisR M Kosinski, P Axelrod, J H Rex, et al.
Diagnostic Microbiology and Infectious Disease|April 1, 1994
A comparison of serial plate agar dilution, Bauer-Kirby disk diffusion, and the Vitek AutoMicrobic system for the determination of susceptibilities of Klebsiella spp., Enterobacter spp., and Pseudomonas aeruginosa to ten antimicrobial agentsT Fekete, H Tumah, J Woodwell, et al.
Radiology|December 1, 1985
Invasive pulmonary aspergillosis and acute leukemia. Limitations in the diagnostic utility of the air crescent signW B Gefter, S M Albelda, G H Talbot, et al.
Chest|July 23, 1998
Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study GroupC A DeAbate, D Henry, G Bensch, et al.
Pageof 8